Making Your First Investment in the Stock Market Through CapitalHeight.
Lupin received tentative approval from the US health regulator for its
Tadalafil tablets, indicated for treating erectile dysfunction and prostate
gland enlargement. The clearance from the United States Food and Drug
Administration (USFDA) is for marketing Tadalafil tablets in strengths of 2.5
mg, 5 mg, 10 mg, and 20 mg, in the US, Lupin said in a statement. The product
is a generic version of Eli Lilly and the company's Cialis tablets in the same
strengths, it added.
For Expert Advice Click here: CapitalHeight.
Shares of Hindalco lost around 8
percent afternoon after reports emerged that it is likely to acquire Aleris for
USD 2.5 billion. According to sources the company and its Canadian arm,
Novelis, is in process of raising debt for the said deal. Investors may have
taken note of this point as the firm already has a consolidated net debt of Rs
40,000 crore. Further, the report added that the companies agreed on terms of
the deal last week.Hindalco is said to be exploring an option of American Depository
Receipts (ADRs).
Shares of Sterlite Technologies fell 5.5 percent despite better
numbers declared by the company in the quarter ended June 2018.The company's
consolidated Q1FY19 net profit was up 7 percent at Rs 121.71 crore against Rs
112.42 crore in Q4FY18.Revenue of the company rose 3.5 percent at Rs 877 crore
against Rs 847 crore. Operating profit or EBITDA was up 11 percent at Rs 245
crore and margin was at 27.9 percent.
For 2 Days Free Trial Click here: Stocks
to Watch.
ReplyDeleteI have read your articles many times and I am always inspired by your tips and knowledge. Thank you for sharing.
Free Trading tips